标题
Drug–Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes
作者
关键词
-
出版物
Pharmaceutics
Volume 12, Issue 12, Pages 1201
出版商
MDPI AG
发表日期
2020-12-14
DOI
10.3390/pharmaceutics12121201
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Drug interaction of ningetinib and gefitinib involving CYP1A1 and efflux transporters in non‐small cell lung cancer patients
- (2020) Lu Liu et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Quantification of Proteins Involved in Drug Metabolism and Disposition in the Human Liver Using Label-Free Global Proteomics
- (2019) Narciso Couto et al. MOLECULAR PHARMACEUTICS
- Clozapine-Associated Myoclonus and Stuttering Secondary to Smoking Cessation and Drug Interaction
- (2019) Megan D. Chochol et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Agomelatine for depression: expanding the horizons?
- (2019) Trevor R. Norman et al. EXPERT OPINION ON PHARMACOTHERAPY
- A Phase I Open-Label Study to Evaluate the Effects of Rifampin on the Pharmacokinetics of Olanzapine and Samidorphan Administered in Combination in Healthy Human Subjects
- (2019) Lei Sun et al. CLINICAL DRUG INVESTIGATION
- Activity and mRNA expression levels of selected cytochromes P450 in various sections of the human small intestine
- (2019) Valérie Clermont et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The Toll-like receptor agonist imiquimod is metabolized by aryl hydrocarbon receptor-regulated cytochrome P450 enzymes in human keratinocytes and mouse liver
- (2019) Melina Mescher et al. ARCHIVES OF TOXICOLOGY
- Highly Variable Expression of CYP1A1 in Human Liver and Impact on Pharmacokinetics of Riociguat and Granisetron in Humans
- (2019) Dieter Lang et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Effect of fluvoxamine augmentation and smoking on clozapine serum concentrations
- (2019) Marc Augustin et al. SCHIZOPHRENIA RESEARCH
- Development and validation of an absolute protein assay for the simultaneous quantification of fourteen CYP450s in human microsomes by HPLC-MS/MS-based targeted proteomics
- (2019) Alexia Grangeon et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- In vitro–in vivo correlation of the drug–drug interaction potential of antiretroviral HIV treatment regimens on CYP1A1 substrate riociguat
- (2019) Natalia A. Jungmann et al. Expert Opinion on Drug Metabolism & Toxicology
- Consumption of baby kale increased cytochrome P450 1A2 (CYP1A2) activity and influenced bilirubin metabolism in a randomized clinical trial
- (2019) Craig S. Charron et al. Journal of Functional Foods
- Abundance of Phase 1 and 2 Drug-Metabolizing Enzymes in Alcoholic and Hepatitis C Cirrhotic Livers: A Quantitative Targeted Proteomics Study
- (2018) Bhagwat Prasad et al. DRUG METABOLISM AND DISPOSITION
- Establishing Transcriptional Signatures to Differentiate PXR-, CAR-, and AhR-Mediated Regulation of Drug Metabolism and Transport Genes in Cryopreserved Human Hepatocytes
- (2018) Jamie E. Moscovitz et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Switching From Tobacco Smoking to Electronic Cigarettes and the Impact on Clozapine Levels
- (2018) Thomas Kocar et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Pharmacogenetics of drug–drug interaction and drug–drug–gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6
- (2017) Muh Akbar Bahar et al. PHARMACOGENOMICS
- Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
- (2017) C. Hiemke et al. PHARMACOPSYCHIATRY
- MicroRNA regulation of CYP 1A2, CYP3A4 and CYP2E1 expression in acetaminophen toxicity
- (2017) Pritmohinder Gill et al. Scientific Reports
- Quantitative Atlas of Cytochrome P450, UDP-Glucuronosyltransferase, and Transporter Proteins in Jejunum of Morbidly Obese Subjects
- (2016) Eisuke Miyauchi et al. MOLECULAR PHARMACEUTICS
- Large-scale multiplex absolute protein quantification of drug-metabolizing enzymes and transporters in human intestine, liver, and kidney microsomes by SWATH-MS: Comparison with MRM/SRM and HR-MRM/PRM
- (2016) Kenji Nakamura et al. PROTEOMICS
- Comparative Proteomic Analysis of Human Liver Tissue and Isolated Hepatocytes with a Focus on Proteins Determining Drug Exposure
- (2015) Anna Vildhede et al. JOURNAL OF PROTEOME RESEARCH
- Evaluation of cytochrome P450 inductions by anti-epileptic drug oxcarbazepine, 10-hydroxyoxcarbazepine, and carbamazepine using human hepatocytes and HepaRG cells
- (2015) Ikuo Sugiyama et al. XENOBIOTICA
- Effect of fosamprenavir/ritonavir on the pharmacokinetics of single-dose olanzapine in healthy volunteers
- (2014) Birgit S. Jacobs et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Expression of P450 and nuclear receptors in normal and end-stage Chinese livers
- (2014) Hong Chen WORLD JOURNAL OF GASTROENTEROLOGY
- Genetics, Epigenetics, and Regulation of Drug-Metabolizing Cytochrome P450 Enzymes
- (2013) U M Zanger et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
- (2013) Ulrich M. Zanger et al. PHARMACOLOGY & THERAPEUTICS
- CYP1A2 rs762551 polymorphism contributes to cancer susceptibility: a meta-analysis from 19 case-control studies
- (2012) Hongge Wang et al. BMC CANCER
- Mass spectrometry-based proteomic analysis of human liver cytochrome(s) P450
- (2012) Kamlesh Shrivas et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- An ‘all-inclusive’ 96-well cytochrome P450 induction method: Measuring enzyme activity, mRNA levels, protein levels, and cytotoxicity from one well using cryopreserved human hepatocytes
- (2012) Jason S. Halladay et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Association of genotypes of carcinogen-metabolizing enzymes and smoking status with bladder cancer in a Japanese population
- (2012) Xiaoyi Cui et al. Environmental Health and Preventive Medicine
- Impact of Smoking, Smoking Cessation, and Genetic Polymorphisms on CYP1A2 Activity and Inducibility
- (2011) M Dobrinas et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Complex Drug Interactions of HIV Protease Inhibitors 2: In Vivo Induction and In Vitro to In Vivo Correlation of Induction of Cytochrome P450 1A2, 2B6, and 2C9 by Ritonavir or Nelfinavir
- (2011) B. J. Kirby et al. DRUG METABOLISM AND DISPOSITION
- Effect of Nuclear Receptor Downregulation on Hepatic Expression of Cytochrome P450 and Transporters in Chronic Hepatitis C in Association with Fibrosis Development
- (2011) Kazuhiko Hanada et al. Drug Metabolism and Pharmacokinetics
- Transcriptional Profiling of Human Liver Identifies Sex-Biased Genes Associated with Polygenic Dyslipidemia and Coronary Artery Disease
- (2011) Yijing Zhang et al. PLoS One
- Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects
- (2010) Lei Yao et al. BREAST CANCER RESEARCH AND TREATMENT
- Profiling Induction of Cytochrome P450 Enzyme Activity by Statins Using a New Liquid Chromatography-Tandem Mass Spectrometry Cocktail Assay in Human Hepatocytes
- (2010) D. M. Feidt et al. DRUG METABOLISM AND DISPOSITION
- Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 −163C>A polymorphism
- (2010) Natasa Djordjevic et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Simultaneous Absolute Quantification of 11 Cytochrome P450 Isoforms in Human Liver Microsomes by Liquid Chromatography Tandem Mass Spectrometry with In Silico Target Peptide Selection
- (2010) Hirotaka Kawakami et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Functional characterization of eight human cytochrome P450 1A2 gene variants by recombinant protein expression
- (2010) B Brito Palma et al. PHARMACOGENOMICS JOURNAL
- Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver
- (2010) Kathrin Klein et al. Frontiers in Pharmacology
- Constitutive androstane receptor transcriptionally activates human CYP1A1 and CYP1A2 genes through a common regulatory element in the 5′-flanking region
- (2009) Kouichi Yoshinari et al. BIOCHEMICAL PHARMACOLOGY
- Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention
- (2009) Vasilis P Androutsopoulos et al. BMC CANCER
- Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis
- (2009) Theodoros N. Sergentanis et al. BREAST CANCER RESEARCH AND TREATMENT
- In Vitro and In Vivo Evaluations of Cytochrome P450 1A2 Interactions with Duloxetine
- (2009) Evelyn D Lobo et al. CLINICAL PHARMACOKINETICS
- A Predominate Role of CYP1A2 for the Metabolism of Nabumetone to the Active Metabolite, 6-Methoxy-2-naphthylacetic Acid, in Human Liver Microsomes
- (2009) M. Turpeinen et al. DRUG METABOLISM AND DISPOSITION
- Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2
- (2009) Shu-Feng Zhou et al. DRUG METABOLISM REVIEWS
- Analysis of humanCYP1A1andCYP1A2genes and their shared bidirectional promoter in eight world populations
- (2009) Lucia F. Jorge-Nebert et al. HUMAN MUTATION
- In vitroInhibition of CYP1A2 by Model Inhibitors, Anti-Inflammatory Analgesics and Female Sex Steroids: Predictability ofin vivoInteractions
- (2008) Marjo J. Karjalainen et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Omeprazole transactivates human CYP1A1 and CYP1A2 expression through the common regulatory region containing multiple xenobiotic-responsive elements
- (2008) Kouichi Yoshinari et al. BIOCHEMICAL PHARMACOLOGY
- Ciprofloxacin Strongly Inhibits Clozapine Metabolism
- (2008) E E M Brouwers et al. CLINICAL DRUG INVESTIGATION
- Steady-State Concentrations of Mirtazapine, N-Desmethylmirtazapine, 8-Hydroxymirtazapine and their Enantiomers in Relation to Cytochrome P450 2D6 Genotype, Age and Smoking Behaviour
- (2008) Anna-Britta Lind et al. CLINICAL PHARMACOKINETICS
- Decreased Expression of Cytochromes P450 1A2, 2E1, and 3A4 and Drug Transporters Na+-Taurocholate-Cotransporting Polypeptide, Organic Cation Transporter 1, and Organic Anion-Transporting Peptide-C Correlates with the Progression of Liver Fibrosis in Chronic Hepatitis C Patients
- (2008) K. Nakai et al. DRUG METABOLISM AND DISPOSITION
- Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms
- (2008) Arzu Gunes et al. PHARMACOGENOMICS
- The Influence of Smoking on the Serum Level of Duloxetine
- (2008) M. Fric et al. PHARMACOPSYCHIATRY
- Pharmacokinetics of olanzapine in Chinese male schizophrenic patients with various smoking behaviors
- (2008) Tzu-Hua Wu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The Tangle of Nuclear Receptors that Controls Xenobiotic Metabolism and Transport: Crosstalk and Consequences
- (2007) Jean-Marc Pascussi et al. Annual Review of Pharmacology and Toxicology
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started